Analyzing Updates from the NCCN Guidelines for Colorectal Cancer Screening
This episode of Clinician's Roundtable features Dr. Reed Ness, an associate professor at Vanderbilt University Medical Center and chairman of the NCCN colorectal cancer screening guidelines committee. He explains that all current guidelines now recommend beginning screening at age 45 for average-risk individuals, a change from the previous age 50. This shift is based on modeling studies showing increased effectiveness and cost-effectiveness, and is prompted by rising colorectal cancer incidence in people under 50. Screening should continue through age 75 for those with a life expectancy of at least 10 years. For ages 76 to 85, decisions are individualized: patients with multiple negative colonoscopies may stop, while those with a history of multiple or large polyps should continue. Dr. Ness emphasizes that alarm symptoms like rectal bleeding, iron deficiency anemia, unexplained abdominal pain, or weight loss should not be dismissed in any patient, regardless of age, and warrant prompt evaluation. For increased-risk groups, the guidelines have specific recommendations. Patients previously treated with chemotherapy should start colonoscopy at age 35 or 10 years after treatment, whichever is later, due to elevated colorectal cancer risk from the therapy itself. Similarly, patients who had radiation therapy involving the abdominal-pelvic field should begin colonoscopy at age 30 or five years after the last treatment, whichever is later, and then be surveyed every five years. The episode concludes by summarizing these key screening considerations for both average and increased-risk patients.
